Neurocrine (NASDAQ: NBIX) grants options and RSUs to director
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NEUROCRINE BIOSCIENCES INC director Leslie V. Norwalk received new equity awards. On May 27, 2026, Norwalk was granted 2,624 non-qualified stock options for common stock with an exercise price of $155.83 per share, expiring on May 27, 2036. These options vest in 12 monthly installments beginning on June 27, 2026.
Norwalk was also granted 1,284 Restricted Stock Units (RSUs), each representing the right to receive one share of common stock upon vesting. The RSUs will vest in full on May 27, 2027. These awards are compensation-related grants rather than open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Norwalk Leslie V
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restriced Stock Unit | 1,284 | $0.00 | -- |
| Grant/Award | Non-Qualified Stock Option | 2,624 | $0.00 | -- |
Holdings After Transaction:
Restriced Stock Unit — 1,284 shares (Direct, null);
Non-Qualified Stock Option — 2,624 shares (Direct, null)
Footnotes (1)
- Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. The RSUs will vest in full on May 27, 2027. Option vests in 12 monthly installments beginning June 27, 2026.
Key Figures
Stock options granted: 2,624 options
Option exercise price: $155.83/share
Option expiration: May 27, 2036
+5 more
8 metrics
Stock options granted
2,624 options
Non-qualified stock option grant on May 27, 2026
Option exercise price
$155.83/share
Exercise price for 2,624 non-qualified stock options
Option expiration
May 27, 2036
Expiration date of non-qualified stock options
RSUs granted
1,284 RSUs
Restricted Stock Unit award on May 27, 2026
RSU vesting date
May 27, 2027
RSUs vest in full on this date
Option vesting schedule
12 monthly installments
Vesting begins June 27, 2026
Options held after grant
2,624 options
Total non-qualified stock options following transaction
RSUs held after grant
1,284 RSUs
Total Restricted Stock Units following transaction
Key Terms
Non-Qualified Stock Option, Restricted Stock Unit ("RSU"), exercise price, vesting, +1 more
5 terms
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Restricted Stock Unit ("RSU") financial
"Each Restricted Stock Unit ("RSU") represents the right to receive one share"
exercise price financial
"conversion_or_exercise_price": "155.8300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The RSUs will vest in full on May 27, 2027."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date": "2036-05-27T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What equity awards did NBIX director Leslie V. Norwalk receive?
Leslie V. Norwalk received 2,624 non-qualified stock options and 1,284 Restricted Stock Units from Neurocrine Biosciences. The options carry a set exercise price, while each RSU represents one future share of common stock upon vesting, reflecting equity-based director compensation.
When do Leslie V. Norwalk’s new NBIX stock options vest?
The 2,624 non-qualified stock options vest in 12 monthly installments beginning June 27, 2026. This monthly vesting spreads the award over one year, aligning option availability with continued board service during that period at Neurocrine Biosciences.
When will Leslie V. Norwalk’s NBIX Restricted Stock Units vest?
Norwalk’s 1,284 Restricted Stock Units will vest in full on May 27, 2027. Upon vesting, each RSU converts into one share of Neurocrine Biosciences common stock, providing the director with additional direct equity ownership at that time.
What is the exercise price and expiration date of the NBIX options granted?
The non-qualified stock options have an exercise price of $155.83 per share and expire on May 27, 2036. This gives Leslie V. Norwalk a long-term window to decide whether to exercise the options, depending on future share price performance.
Are Leslie V. Norwalk’s NBIX Form 4 transactions open-market buys or sells?
No, the Form 4 shows grant or award acquisitions, not open-market buys or sells. The transactions are coded as awards of options and RSUs to Leslie V. Norwalk as part of compensation, with no reported market purchases or sales of existing shares.